BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS
Jun 9, 2022
Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021
Jun 3, 2022
Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA TARGETS MOST PROFITABLE DRUGS FOR NEW FORMULATIONS TO BLOCK COMPETITION
May 25, 2022
Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster… Read More
BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS
May 13, 2022
Part D Spending on 10 Most Popular Medications Over Five Years Averages Five… Read More
BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER
May 6, 2022
Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After… Read More
DOSE OF REALITY: SENATE COMMERCE HEARING OPPORTUNITY FOR LAWMAKERS TO HOLD BIG PHARMA ACCOUNTABLE
May 3, 2022
Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, GLAXOSMITHKLINE, AMGEN, ROCHE
Apr 29, 2022
Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 20, 2022
J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After… Read More
BIG PHARMA WATCH: BRANDED DRUG COMPANIES MORE THAN DOUBLED PRICES FOR BLOCKBUSTER BLOOD THINNING MEDICATIONS OVER TEN YEARS
Apr 7, 2022
New Report Demonstrates How Brand Name Drug Companies Work in “Lockstep”… Read More
DOSE OF REALITY: NEW STUDY FINDS ONE THIRD OF SENIORS DO NOT FILL PRESCRIPTIONS FOR HIGH-PRICE DRUGS USED TO TREAT SERIOUS CONDITIONS
Apr 6, 2022
Academic Study Underscores How Big Pharma’s Price-Gouging on Treatments for… Read More
THEY SAID IT! FINANCE COMMITTEE HIGHLIGHTS URGENCY TO HOLD BIG PHARMA ACCOUNTABLE FOR PRICE HIKES AND ANTI-COMPETITIVE BEHAVIOR
Mar 17, 2022
Lawmakers Double-Down on Repeated Promises to the American People to Lower… Read More
DOSE OF REALITY: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE IN SENATE FINANCE HEARING
Mar 14, 2022
Congress Can Refocus Attention on Market-Based Solutions to Crack Down on… Read More